Diuretic-Enhanced Dual-Phase F-18 FDG PET/CT: A New Window Into Muscle-Invasive Bladder Cancer
Cihan Şin, Burcu Esen Akkaş, Özge Vural Topuz, Özgür Omak, Enes M. Kaya, Harun Özdemir, Begüm Çalım Gürbüz, Halil L. Canat, Abdulmuttalip Şimşek, Meryem Kaya · 2026
Read Diuretic-Enhanced Dual-Phase F-18 FDG PET/CT: A New Window Into Muscle-Invasive Bladder Cancer by Cihan Şin, Burcu Esen Akkaş, Özge Vural Topuz, Özgür Omak, Enes M. Kaya, Harun Özdemir, Begüm Çalım Gürbüz, Halil L. Canat, Abdulmuttalip Şimşek, Meryem Kaya (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13612137.txt.
Description
Cihan Şin leads a ten-author team testing a scanning trick for bladder cancer in 2026. The tracer used in FDG PET scans drains into the bladder and can hide tumors in its wall. The team gave patients the diuretic furosemide and imaged twice to flush the view. Their question was practical: can the scan tell whether cancer has invaded the bladder muscle, the fact that decides between bladder-sparing treatment and major surgery? The cohort held 105 patients.
Distant spread turned up in 30 patients, changing their management. Among 75 patients who went on to surgical sampling, the scan separated malignant from benign lesions with 78.0 percent sensitivity. In the 59 confirmed cancers, every measured quantity ran higher in muscle-invasive T2 tumors than in shallower ones. Volume and glycolysis measures discriminated best: area-under-curve 0.814 for the first and 0.830 for the second. The authors propose these numbers as stand-in markers for preoperative staging.
Catalog record
| CREATOR | Cihan Şin, Burcu Esen Akkaş, Özge Vural Topuz, Özgür Omak, Enes M. Kaya, Harun Özdemir, Begüm Çalım Gürbüz, Halil L. Canat, Abdulmuttalip Şimşek, Meryem Kaya |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 28761 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |